Diabetes Type1

3

Review clinical trials related to Diabetes Type1. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

This study is designed to compare two behavioral approaches to reduce diabetes distress ("the expected burdens, concerns, fears, and threats that arise from the challenges of living with diabetes") in adults with type 1 diabetes. At the study baseline, participants will be randomized to take part in one of two virtual, group-based interventions (the "Primary" intervention) utilizing either an emotions-focused or a problem-solving approach to reduce diabetes distress. After the initial intervention, participants will complete surveys to assess their response to the material. Participants who are determined to be "non-responders" (i.e., the Primary intervention was not effective) will be re-randomized to one of two "Supplementary" interventions, which will include individualized sessions to learn and/or practice strategies related to either the psychological or problem-solving approach.

Participants needed: 200
Trial details
Age: 30+Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Oct 29, 2025Locations: 1
Eligibility criteria

Adults 30 years and older [+3]

Does not receive diabetes care at UNC Endocrinology at Eastowne [+5]

Status: Recruiting

Exploration of Health Literacy in Diabetes in Reunion Island and France

The goal of this observational study is to identify the health literacy profile of diabetic patients in Reunion Island and France in order to obtain information to improve access to information, therapeutic education and to health service. The main question\[s\] it aims to answer \[is/are\]: Participants will complete the Health Literacy Questionnaire (HLQ) once.

Participants needed: 1,350
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Centre Hospitalier Universitaire de la RéunionUpdated: Jul 30, 2025Locations: 2
Eligibility criteria

Patient unable to understand and respect study procedures [+4]

Status: Recruiting

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

More than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity. Each of these diagnoses increase the risk of adverse cardiovascular events. GLP-1 analogues are anti-obesity medications that are cardioprotective in adults with type 2 diabetes, however evaluation of these agents in people with T1D has been limited to glycemic outcomes. Investigators aim to study the impact of GLP-1 analogue obesity treatment on markers of cardiometabolic risk in young adults with T1D and obesity.

Participants needed: 54
Trial details
Phase: Phase 2Age: 18-30Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: May 2, 2025Locations: 1
Eligibility criteria

Age 18-30 years with T1D whose BMI meets FDA approval criteria for anti-obesity... [+13]

Use of adjunctive diabetes therapies or anti-obesity medications (including any... [+16]